Table 3.
UV |
MV |
|||||||
---|---|---|---|---|---|---|---|---|
Hazard Ratio |
95% Lower CL | 95% Upper CL | P-Value | Hazard Ratio |
95% Lower CL | 95% Upper CL | P-Value | |
Age (Continuous) | 1.047 | 0.974 | 1.126 | 0.215 | 1.040 | 0.952 | 1.136 | 0.383 |
Gender | ||||||||
Male | 1.000 | |||||||
Female | 1.195 | 0.524 | 2.726 | 0.672 | 1.545 | 0.633 | 3.772 | 0.340 |
Race | ||||||||
White | 1.000 | |||||||
Other | 1.593 | 0.698 | 3.634 | 0.268 | 1.656 | 0.706 | 3.886 | 0.246 |
Tumor Size Laterality | 1.124 | 1.003 | 1.258 | 0.044 | 1.120 | 1.005 | 1.247 | 0.040 |
Left | 1.000 | |||||||
Right | 0.655 | 0.258 | 1.661 | 0.373 | 0.680 | 0.264 | 1.752 | 0.424 |
SEER Summary Stage | ||||||||
Regional | 1.000 | |||||||
Distant | 1.491 | 0.658 | 3.380 | 0.339 | 1.304 | 0.558 | 3.048 | 0.540 |
LNY | ||||||||
≤6 LNs | 1.000 | |||||||
>6 LNs | 0.762 | 0.334 | 1.739 | 0.519 | 1.227 | 0.468 | 3.217 | 0.678 |
LND (Continuous) | 3.915 | 1.085 | 14.125 | 0.037 | 3.753 | 0.851 | 16.545 | 0.081 |